Insight to health and wellness for traditional and modern medicine.
Aducanumab is a medicine to treat Alzheimer’s disease by Biogen. The U.S. Food and Drug Administration (FDA) granted the priority review of aducanumab in August 2020. The FDA also set a start date for the Prescription Drug User Fee Act of 7 March 2021. Currently, the review is in progress. …
Coronavirus disease (COVID-19) is a recently discovered infectious viral disease. Coronavirus causes it, and most people infected with the COVID-19 virus will experience mild to moderate respiratory distress and recover without needing advanced medical care. It was believed that aged people are most likely to experience severe illnesses. People with …
